Skip to main content
. Author manuscript; available in PMC: 2024 Aug 1.
Published in final edited form as: Am J Gastroenterol. 2023 Apr 11;118(8):1457–1460. doi: 10.14309/ajg.0000000000002283

Figure 2:

Figure 2:

Drinks per week in patients with moderate alcohol-associated hepatitis (mAH) receiving LGG or placebo at baseline, and at 6-month time-period. BL: Baseline, LGG: Lactobacillus GG, 6M: 6-month timeline, PL: Placebo. Data presented as Mean ± Standard Deviation. Statistical significance was set at p<0.05. ***p<0.001, *p<0.05.